ID Source | ID |
---|---|
PubMed CID | 188317 |
MeSH ID | M0080583 |
Synonym |
---|
anhydrocyprinol |
3692-27-1 |
(3r,5r,7r,8r,9s,10s,12s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-5-(oxetan-3-yl)pentan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene-3,7,12-triol |
(3alpha,5alpha,7alpha,12alpha)-26,27-epoxycholestane-3,7,12-triol |
26,27-oxido-5alpha-cholestane-3alpha,7alpha,12alpha-triol |
DTXSID80958116 |
26,27-epoxycholestane-3,7,12-triol |
Excerpt | Reference | Relevance |
---|---|---|
"To elucidate the responsible toxic components of grass carp bile, the bile salt 5 alpha-cyprinol sulfate and its desalted form 5 alpha-cyprinol from grass carp bile were purified and identified by analyses of infrared spectrum, (1)H-, (13)C-nuclear magnetic resonance spectra and mass spectrum." | ( Identification of cyprinol and cyprinol sulfate from grass carp bile and their toxic effects in rats. Deng, JF; Hwang, DF; Lai, YS; Yeh, YH, ) | 0.13 |
"We compared the short-term toxicity of toxic components of grass carp bile juice (GCBJ) in rats." | ( Short-term toxicity of grass carp bile powder, 5alpha-cyprinol and 5alpha-cyprinol sulfate in rats. Chen, SK; Deng, JF; Hwang, DF; Wang, DY; Yeh, YH, 2002) | 0.31 |
" The toxicity of 5alpha-cyprinol sulfate/chenodeoxycholic acid (9:1) and 5alpha-cyprinol sulfate was similar to each other, and the toxic effect of chenodeoxycholic acid was less." | ( Effect of chenodeoxycholic acid on the toxicity of 5alpha-cyprinol sulfate in rats. Chen, SK; Deng, JF; Hwang, DF; Wang, DY; Yeh, YH, 2002) | 0.31 |
Excerpt | Reference | Relevance |
---|---|---|
"3 mM) and was poorly absorbed from the perfused rat jejunum or ileum." | ( Physicochemical and physiological properties of 5alpha-cyprinol sulfate, the toxic bile salt of cyprinid fish. Cerrè, C; Goto, T; Hagey, LR; Hofmann, AF; Holzinger, F; Schteingart, CD; Shneider, BL; Steinbach, JH; Ton-Nu, HT, 2003) | 0.32 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (20.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.33) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 2 (18.18%) | 6.00% |
Case Studies | 1 (9.09%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (72.73%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |